United States Antimony enters its third-quarter report with a credibility problem and a delivery schedule that could help repair it. Three months ago, management cut its 2026 revenue target roughly in half, to $60 million to $75 million from the $125 million it had reaffirmed on three straight calls. The reason was collapsing antimony prices, not weak demand. The September quarter is the first real chance to show that the volume story is strong enough to carry the business while prices stay low.

The Street is asking for a lot. Consensus calls for revenue of about $17.1 million, up nearly 96% from $8.7 million a year ago. That would be more than double the $7.9 million booked in the second quarter. Analysts expect a loss of about a penny per share, an improvement from the four-cent loss a year earlier. The full-year picture is less settled. Consensus for 2026 still sits near $113 million, far above the top of management's range. That figure looks stale rather than a real bet against the company. But it does mean any quarterly number has to be read against the lowered guide, not the old one.

Much of the case for a big sequential jump rests on the Defense Logistics Agency contract. The first roughly 82,000 pounds of ingots shipped in June, but government inspection and acceptance pushed that revenue into the third quarter. Management said later truckloads should add about $2.6 million of cash flow in the third quarter and about $4 million in the fourth. It also expects to finish the first $9.9 million order about a year early. The report should show whether recognition is keeping pace with physical shipments. A second slip would hit the quarter and suggest that government paperwork, not production, now sets the timing of revenue.

The other numbers to examine are pounds sold and margins. Antimony volume rose about 26% year over year last quarter, while realized prices fell about 52% to $13.70 per pound. Gross margin dropped to 7% from 27% a year earlier. Cost per pound fell about a third, to $13.34, but that left almost no cushion against realized prices. The management narrative holds up if volume keeps climbing, Bolivian metal starts contributing, zeolite keeps growing at its recent triple-digit pace, and unit costs fall faster than prices. The narrative weakens if gross margin stays in single digits. So does any sign that operating expenses of $7.6 million, which have more than doubled, are a permanent base rather than a peak.

The bottom line could be messy. Second-quarter profit was propped up by a $6.8 million unrealized gain on the Larvado stake, and about $2.7 million of that had reversed shortly after quarter end. With the takeover effort being abandoned and the stake recast as a source of cash, another mark could swing reported earnings either way. Operating results are the better guide. Cash use also matters after a $20.7 million first-half burn tied to building inventory. Investors should want to see that inventory turning into DLA and commercial sales. Development timelines at Thompson Falls and the hydrometallurgical projects have slipped repeatedly, so any firm dates would carry weight.

The market has already punished the reset. Shares have fallen about 36% since the last report, while the S&P 500 slipped about 3%. At $3.47, the stock sits well below its 200-day average near $7.07 and in the lower third of its post-earnings range of $2.53 to $5.78. Bearish sentiment has grown sharply versus a quarter ago. That sets a lower emotional bar, even though the revenue consensus remains demanding. The central question is whether higher volume and DLA revenue can produce a step-change in sales without margins deteriorating further. If they do, the cut guidance starts to look like a pricing story the company can outlast. If they do not, the lowered range may still prove too high.